Epstein-Barr Virus (EBV-gp125 VCA) Antigen

Recombinant viral capsid glycoprotein reagent for Epstein-Barr virus serology research, supplied by Antibodies.com as a 1 mL liquid preparation ready for direct dilution into ELISA plate-coating workflows and Western Blot confirmation of VCA-specific immunoreactivity. The gp125 component is a principal target of the host humoral response to EBV, making this antigen a useful reagent for studies of acute infection, past-exposure profiling, and EBV-linked disease models including infectious mononucleosis and virus-associated lymphoproliferative conditions.

Validated application areas cover immunoassay development (ELISA) and immunoblot confirmation (WB), supporting both screening assays and confirmatory testing strategies in clinical virology and immunology laboratories. The liquid format removes the need for initial reconstitution, allowing rapid dilution into coating buffers or PAGE loading buffer depending on the chosen workflow. Researchers investigating EBV epidemiology, viral reactivation, or antibody cross-reactivity will find this antigen useful as a reference reagent for in vitro diagnostic development.

Store refrigerated and protect from light; aliquot upon first use to limit repeated freeze-thaw events when the reagent is held for extended bench campaigns. Each vial is supplied as a single-use 1 mL liquid aliquot, individually packaged for one-time assay setup.